Video

Dr. Rugo on the Significance of Becoming a Giant in Cancer Care

Author(s):

Hope S. Rugo, MD, discusses the significance of becoming a Giant of Cancer Care®.

Hope S. Rugo, MD, a professor in the Department of Medicine, Hematology/Oncology, and director of Breast Oncology and Clinical Trials Education at University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, discusses the significance of becoming a Giant of Cancer Care®.

It is an honor to be recognized as a Giant in Cancer Care® in Education and to join other esteemed physicians who have held the title in education, breast cancer, and other malignancies, Rugo says. The 2020 award ceremony was held virtually for the first time, Rugo adds, and several moving speeches were delivered throughout the night.

Attendees were afforded the opportunity to hear about all the contributions that their colleagues are making in the field of oncology, and all these advances are benefitting patients around the world, Rugo adds.

Rugo will serve as chair of the the steering committee for the 2021 Giants in Cancer Care® ceremony.

Related Videos
Peter Schmid, MD, PhD, FRCP, discusses updated KEYNOTE-522 data showing that pembrolizumab plus chemotherapy improves EFS in early-stage TNBC.
David Rimm, MD, PhD
Vered Stearns, MD
Ruth M. O’Regan, MD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Sheldon M. Feldman, MD
Dana Zakalik, MD
Alberto Montero, MD, MBA, CPHQ
Jairam Krishnamurthy, MD, FACP
Deena Mary Atieh Graham, MD